These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4038373)

  • 1. Thrombolysis with recombinant tissue plasminogen activator in atherosclerotic thrombotic occlusion.
    Topol EJ; Ciuffo AA; Pearson TA; Dillman J; Builder S; Grossbard E; Weisfeldt ML; Bulkley BH
    J Am Coll Cardiol; 1985 Jan; 5(1):85-91. PubMed ID: 4038373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human extrinsic plasminogen activator fibrinolytic properties and neutralization in vivo.
    Mattsson C; Nilsson S; Häggroth L
    Thromb Res; 1983 Apr; 30(1):91-100. PubMed ID: 6683005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D; Stassen JM; Verstraete M
    J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasis.
    Flameng W; Vanhaecke J; Stump DC; Van de Werf F; Holmes W; Guenzler WA; Flohe L; Collen D
    J Am Coll Cardiol; 1986 Jul; 8(1):118-24. PubMed ID: 3086416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction.
    Meneveau N; Schiele F; Vuillemenot A; Valette B; Grollier G; Bernard Y; Bassand JP
    Eur Heart J; 1997 Jul; 18(7):1141-8. PubMed ID: 9243149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.
    Agnelli G; Buchanan MR; Fernandez F; Boneu B; Van Ryn J; Hirsh J; Collen D
    Circulation; 1985 Jul; 72(1):178-82. PubMed ID: 4039986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful clot lysis using low dose of streptokinase in 22 neonates with aortic thromboses.
    Cheah FC; Boo NY; Rohana J; Yong SC
    J Paediatr Child Health; 2001 Oct; 37(5):479-82. PubMed ID: 11885713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clot-selective coronary thrombolysis with tissue-type plasminogen activator.
    Bergmann SR; Fox KA; Ter-Pogossian MM; Sobel BE; Collen D
    Science; 1983 Jun; 220(4602):1181-3. PubMed ID: 6602378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.
    Korninger C; Matsuo O; Suy R; Stassen JM; Collen D
    J Clin Invest; 1982 Mar; 69(3):573-80. PubMed ID: 7199539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
    Collen D; Topol EJ; Tiefenbrunn AJ; Gold HK; Weisfeldt ML; Sobel BE; Leinbach RC; Brinker JA; Ludbrook PA; Yasuda I
    Circulation; 1984 Dec; 70(6):1012-7. PubMed ID: 6388898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected].
    Lyden PD; Madden KP; Clark WM; Sasse KC; Zivin JA
    Stroke; 1990 Nov; 21(11):1589-93. PubMed ID: 2122552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D; Bounameaux H
    Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.
    Van de Werf F; Bergmann SR; Fox KA; de Geest H; Hoyng CF; Sobel BE; Collen D
    Circulation; 1984 Mar; 69(3):605-10. PubMed ID: 6362907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
    Gulba DC; Tanswell P; Dechend R; Sosada M; Weis A; Waigand J; Uhlich F; Hauck S; Jost S; Rafflenbeul W; Lichtlen PR; Dietz R
    J Am Coll Cardiol; 1997 Dec; 30(7):1611-7. PubMed ID: 9385884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
    J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local thrombolysis in peripheral arterial occlusion].
    Hess H
    Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.
    Van de Werf F; Ludbrook PA; Bergmann SR; Tiefenbrunn AJ; Fox KA; de Geest H; Verstraete M; Collen D; Sobel BE
    N Engl J Med; 1984 Mar; 310(10):609-13. PubMed ID: 6537987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term results after thrombolytic treatment of deep venous thrombosis.
    Schweizer J; Kirch W; Koch R; Elix H; Hellner G; Forkmann L; Graf A
    J Am Coll Cardiol; 2000 Oct; 36(4):1336-43. PubMed ID: 11028492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.